Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Vor Biopharma Inc. before investing.

In this article, we go over a few key elements for understanding Vor Biopharma Inc.’s stock price such as:

• Vor Biopharma Inc.’s current stock price and volume
• Why Vor Biopharma Inc.’s stock price changed recently
• Upgrades and downgrades for VOR from analysts
• VOR’s stock price momentum as measured by its relative strength

About Vor Biopharma Inc. (VOR)

Before we jump into Vor Biopharma Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren’s disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Want to learn more about Vor Biopharma Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Vor Biopharma Inc..

Vor Biopharma Inc.’s Stock Price as of Market Close

As of August 21, 2026, 4:00 PM, CST, Vor Biopharma Inc.’s stock price was $23.360.

Vor Biopharma Inc. is up 1.28% from its previous closing price of $23.065.

During the last market session, Vor Biopharma Inc.’s stock traded between $23.070 and $23.860. Currently, there are approximately 54.30 million shares outstanding for Vor Biopharma Inc..

Vor Biopharma Inc.’s price-earnings (P/E) ratio is currently at 1.2, which is low compared to the Biotechnology industry median of 19.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Vor Biopharma Inc. Stock Price History

Vor Biopharma Inc.’s (VOR) price is currently up 10.45% so far this month.

During the month of August, Vor Biopharma Inc.’s stock price has reached a high of $24.540 and a low of $20.170.

Over the last year, Vor Biopharma Inc. has hit prices as high as $50.200 and as low as $6.500. Year to date, Vor Biopharma Inc.’s stock is up 78.59%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Vor Biopharma Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 21, 2026, there was 1 analyst who downgraded Vor Biopharma Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Vor Biopharma Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Vor Biopharma Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Vor Biopharma Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Vor Biopharma Inc. (VOR) by visiting AAII Stock Evaluator.

Relative Price Strength of Vor Biopharma Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 21, 2026, Vor Biopharma Inc. has a weighted four-quarter relative price strength of 22.27%, which translates to a Momentum Score of 92 and is considered to be Very Strong.

Want to learn more about how Vor Biopharma Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Vor Biopharma Inc. Stock Price: Bottom Line

As of August 21, 2026, Vor Biopharma Inc.’s stock price is $23.360, which is up 1.28% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Vor Biopharma Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.